Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 13,423 $ 10,800
Premium and trade receivables 11,516 9,696
Short-term investments 1,517 1,580
Other current assets 1,600 1,317
Total current assets 28,056 23,393
Long-term investments 13,561 12,853
Restricted deposits 1,114 1,060
Property, software and equipment, net 3,302 2,774
Goodwill 19,699 18,652
Intangible assets, net 8,143 8,388
Other long-term assets 3,868 1,599
Total assets 77,743 68,719
Current liabilities:    
Medical claims liability 14,099 12,438
Accounts payable and accrued expenses 8,089 7,069
Return of premium payable 2,238 1,458
Unearned revenue 371 523
Current portion of long-term debt 245 97
Total current liabilities 25,042 21,585
Long-term debt 18,594 16,682
Deferred tax liability 1,440 1,534
Other long-term liabilities 5,993 2,956
Total liabilities 51,069 42,757
Commitments and contingencies
Redeemable noncontrolling interests 84 77
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2021 and December 31, 2020 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 600,708 issued and 583,500 outstanding at September 30, 2021, and 598,249 issued and 581,479 outstanding at December 31, 2020 1 1
Additional paid-in capital 19,594 19,459
Accumulated other comprehensive earnings 176 337
Retained earnings 7,540 6,792
Treasury stock, at cost (17,208 and 16,770 shares, respectively) (845) (816)
Total Centene stockholders’ equity 26,466 25,773
Nonredeemable noncontrolling interest 124 112
Total stockholders’ equity 26,590 25,885
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 77,743 $ 68,719